News | Computed Tomography (CT) | August 08, 2016

Findings of ultra-low cost study reveal more differences in CT lung cancer screening protocols than expected, highlighting need for better communication, education and resources

CT lung cancer screening, computed tomography, crowd-sourced study, image quality, Prevent Cancer Foundation workshop

August 8, 2016 — An overview of the initial findings and results from the CT Lung Screening Protocol Challenge was announced at the Prevent Cancer Foundation Quantitative Imaging Workshop on June 13, 2016.

This first-of-its-kind study allowed researchers to evaluate the protocols and image quality performance of currently-deployed computed tomography (CT) scanners for low-dose CT lung cancer screening. The researchers also obtained initial data on the applicability of these scanners and protocols for chronic obstructive pulmonary disease (COPD). The use of 3M Scotch Magic tape as an image quality reference object provided an ultra-low cost and novel method of evaluating fundamental CT image quality performance across a scanner’s field of view. 3M Scotch tape is manufactured so that this product’s dimensions are extremely consistent.

Over a two-month data collection period, the information received from CT lung cancer screening image data was automatically analyzed. Data were received from 26 healthcare institutions, 53 CT scanners and approximately 128 individual CT scans. Preliminary analysis of the study data revealed larger differences in CT scanning protocols than expected, despite low-dose lung cancer screening recommendations and guidelines from major societies. These data highlighted the need for more communication, education and resources for establishing and verifying CT imaging protocols.

The study data also revealed a critical need to continue collecting large databases of image quality data and also revealed many opportunities to improve CT scanners and imaging methods to better support detection and quantitative measurement of early lung disease.

The Challenge data review committee is now preparing a manuscript of the preliminary Challenge findings, which will be submitted for review in August.

For more information: www.preventcancer.org


Related Content

News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
News | FDA

April 16, 2026 — Royal Philips has received U.S. Food and Drug Administration 510(k) clearance for the Philips Spectral ...

Time April 20, 2026
arrow
News | Radiology Imaging

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the ...

Time April 09, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
Subscribe Now